Brief: Castle Biosciences Q4 Basic EPS USD -0.1
28/02/2024 21:05
Feb 28 (Reuters) - Castle Biosciences Q4 operating income USD -5.658 million. * Q4 net income USD -2.58 million * Q4 pretax profit USD -2.541 million * Q4 revenue USD 66.12 million vs. IBES estimate USD 56.3 million * Q4 operating expenses USD 71.778 million
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million